Prokidney to present at upcoming investor conferences

Winston-salem, n.c., may 20, 2022 (globe newswire) -- prokidney lp (prokidney), a leading clinical-stage cellular therapeutics company focused on the treatment of chronic kidney disease (ckd) and the prevention of both end-stage renal disease (esrd) and the need for dialysis, today announced that tim bertram, phd, chief executive officer, will present at the following investor conferences:
PROK Ratings Summary
PROK Quant Ranking